New investment – Desktop Genetics

We are delighted to have participated in a seed funding round for Desktop Genetics. The company produces software used in the design and execution of genome editing experiments, a market that is experiencing enormous growth. The company’s core platform, DESKGEN, is used with the world-leading CRISPR/Cas editing technology.